IFIH1 and dermatomyositis: Anti-melanoma differentiation-associated protein 5 antibody-positive dermatomyositis (anti-MDA5-DM), which often presents as clinically amyopathic dermatomyositis (CADM), is associated with progressive ILD and has a poor prognosis [1].